116 related articles for article (PubMed ID: 2981622)
1. Pharmacokinetics of etoposide in gestochoriocarcinoma.
D'Incalci M; Sessa C; Rossi C; Roviaro G; Mangioni C
Cancer Treat Rep; 1985 Jan; 69(1):69-72. PubMed ID: 2981622
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients.
Hande KR; Wedlund PJ; Noone RM; Wilkinson GR; Greco FA; Wolff SN
Cancer Res; 1984 Jan; 44(1):379-82. PubMed ID: 6690051
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability, pharmacokinetics, and clinical effects of an oral preparation of etoposide.
Stewart DJ; Nundy D; Maroun JA; Tetreault L; Prior J
Cancer Treat Rep; 1985 Mar; 69(3):269-73. PubMed ID: 3884152
[TBL] [Abstract][Full Text] [Related]
4. [Anticancer effect of VP16-213 (etoposide) on three choriocarcinoma cell lines].
Matsui H; Kobayashi O; Shirotake S; Sekiya S; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jun; 39(6):933-9. PubMed ID: 3611870
[TBL] [Abstract][Full Text] [Related]
5. Oral etoposide in gestational trophoblastic disease.
Wong LC; Choo YC; Ma HK
Cancer Treat Rep; 1984 May; 68(5):775-7. PubMed ID: 6327035
[TBL] [Abstract][Full Text] [Related]
6. Use of oral VP16-213 as primary chemotherapeutic agent in treatment of gestational trophoblastic disease.
Wong LC; Choo YC; Ma HK
Am J Obstet Gynecol; 1984 Dec; 150(8):924-7. PubMed ID: 6095666
[TBL] [Abstract][Full Text] [Related]
7. Primary oral etoposide therapy in gestational trophoblastic disease. An update.
Wong LC; Choo YC; Ma HK
Cancer; 1986 Jul; 58(1):14-7. PubMed ID: 3011237
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumour activity of the epipodophyllin derivative VP16-213 (etoposide: NSC-141540) in gestational choriocarcinoma.
Newlands ES; Bagshawe KD
Eur J Cancer (1965); 1980 Mar; 16(3):401-5. PubMed ID: 6154579
[No Abstract] [Full Text] [Related]
9. Pharmacokinetic evaluation of increasing dosages of etoposide in a chronic hemodialysis patient.
Holthuis JJ; Van de Vyver FL; van Oort WJ; Verleun H; Bakaert AB; De Broe ME
Cancer Treat Rep; 1985 Nov; 69(11):1279-82. PubMed ID: 3004725
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of etoposide in patients with abnormal renal and hepatic function.
D'Incalci M; Rossi C; Zucchetti M; Urso R; Cavalli F; Mangioni C; Willems Y; Sessa C
Cancer Res; 1986 May; 46(5):2566-71. PubMed ID: 3697995
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of VP16-213 given by different administration methods.
D'Incalci M; Farina P; Sessa C; Mangioni C; Conter V; Masera G; Rocchetti M; Pisoni MB; Piazza E; Beer M; Cavalli F
Cancer Chemother Pharmacol; 1982; 7(2-3):141-5. PubMed ID: 7083454
[TBL] [Abstract][Full Text] [Related]
12. [Anti-tumor and adverse effect of etoposide and cisplatin on human choriocarcinoma transplanted to nude mice--a correlation between effect and tissue distribution of the drugs].
Adachi S; Yoshiya N; Misawa Y; Ishida M; Kanazawa K; Takeuchi S; Tanaka K
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2031-6. PubMed ID: 3794452
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability and pharmacokinetics of etoposide (VP-16).
Smyth RD; Pfeffer M; Scalzo A; Comis RL
Semin Oncol; 1985 Mar; 12(1 Suppl 2):48-51. PubMed ID: 3975657
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of etoposide after intrathoracic instillation to lung cancer patients with pleural effusion.
Wada I; Yokouchi M; Saitoh H; Takada M; Nakabayashi T; Mino K; Honma T; Takeda T; Hirano K
Int J Clin Pharmacol Ther; 1999 May; 37(5):254-9. PubMed ID: 10363625
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of VP16-213 in Lewis lung carcinoma bearing mice.
Colombo T; Broggini M; Torti L; Erba E; D'Incalci M
Cancer Chemother Pharmacol; 1982; 7(2-3):127-31. PubMed ID: 7083453
[TBL] [Abstract][Full Text] [Related]
16. The role of VP16-213 (etoposide; NSC-141540) in gestational choriocarcinoma.
Newlands ES; Bagshawe KD
Cancer Chemother Pharmacol; 1982; 7(2-3):211-4. PubMed ID: 7083462
[TBL] [Abstract][Full Text] [Related]
17. Etoposide.
N Engl J Med; 1985 Aug; 313(8):518-9. PubMed ID: 2991763
[No Abstract] [Full Text] [Related]
18. Pharmacokinetics of teniposide in patients with ovarian cancer.
D'Incalci M; Rossi C; Sessa C; Urso R; Zucchetti M; Farina P; Mangioni C
Cancer Treat Rep; 1985 Jan; 69(1):73-7. PubMed ID: 3967261
[TBL] [Abstract][Full Text] [Related]
19. Activity and pharmacokinetics of teniposide in Lewis lung carcinoma-bearing mice.
Broggini M; Colombo T; D'Incalci M
Cancer Treat Rep; 1983 Jun; 67(6):555-9. PubMed ID: 6861161
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumors.
Sinkule JA; Hutson P; Hayes FA; Etcubanas E; Evans W
Cancer Res; 1984 Jul; 44(7):3109-13. PubMed ID: 6539169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
